© 2001 by European Society of Cardiology
REGULAR ARTICLES
Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma?
Cardiac Arrhythmia Center, University of Minnesota Minneapolis, MN, 55455, U.S.A
A 30-year-old Caucasian male was referred for evaluation of a 2-year history of recurrent post-exertion lightheadedness and near syncopal spells in the setting of a family history of unexplained sudden cardiac death. Cardiac evaluation demonstrated normal heart structure, but the 12-lead surface ECG was suggestive of but not diagnostic of Brugada syndrome. An exercise stress test reproduced the patient's usual symptoms during the recovery period, and was consistent with a typical vasovagal faint. The same symptoms were observed during a head-up tilt table test. However, given the family history and ECG, pharmacological testing with procainamide, isoprenaline and metoprolol, as well as programmed ventricular stimulation, were undertaken. Pharmacological provocation further supported a diagnosis of Brugada syndrome, whereas programmed ventricular stimulation was considered non-diagnostic regarding ventricular tachyarrhythmia susceptibility. Consequently, despite ECG and pharmacological findings suggestive of Brugada syndrome, there appeared to be sufficient evidence to believe that this patient's symptoms were the result of neurally mediated syncope and not due to ventricular tachyarrhythmias. The patient was treated with midodrine, and has remained symptom-free for 16 months. Thus, given the frequency with which vasovagal syncope occurs in young patients, its occurrence is not unexpected in individuals with concomitant diagnoses such as Brugada syndrome. In as much as current recommendations favour implantable defibrillators in symptomatic Brugada syndrome, the identification of other causes of syncope in such patients poses an uncomfortable, and currently unsettled dilemma.
Key Words: Vasovagal syncope, Brugada syndrome, head-up tilt table testing
Correspondence: David G. Benditt, Cardiac Arrhythmia Center, 420 Delaware Street SE, MMC 508, University of Minnesota Medical School, Minneapolis, MN 55455, U.S.A. E-mail: bendi001{at}tc.umn.edu
[1] Wever EFD, Hauer RNW, Oomen A, Peters RHJ, Robles de Medina EO. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993; 88: 1021–1029.
[2] Viskin S and Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990; 120: 661–671.[CrossRef][Web of Science][Medline]
[3] Viskin S and Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of heart disease: Classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis 1998; 41: 1–19.[Web of Science][Medline]
[4] Brugada P and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391–1396.[Abstract]
[5] Priori S and Paganini V. Idiopathic ventricular fibrillation: A clinical prognostic and therapeutic dilemma. Data from international registry of IVF (USARE) (abstract). Eur J Cardiac Pacing Electrophysiol 1996; 6: 5.
[6] Mewis C, Kuhlkamp V, Spyridopoulos I. Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol 1998; 81: 999–1003.[CrossRef][Web of Science][Medline]
[7] Miyfazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061–1070.[Abstract]
[8] Brugada J and Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation and sudden cardiac death. J Cardiovasc Electrophysiol 1997; 8: 325–331.[Web of Science][Medline]
[9] Benditt DG, Ferguson DW, Grubb BP, Bosch RF, Seiple L, et al. Tilt-table testing for assessing syncope and its treatment: An American College of Cardiology expert consensus document. J Am Coll Cardiol 1996; 28: 263–275.[CrossRef][Web of Science][Medline]
[10] Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293–296.[CrossRef][Medline]
[11] Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block ST elevation in V1 to V3 and sudden death—the Brugada syndrome. Europace 1999; 1: 156–166.
[12] Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101: 510–515.
[13] Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. Are asymptomatic patients at high risk for sudden death. In Raviele A (Ed.). Cardiac Arrhythmias 1999 2000; Milan Springer-Verlag pp. 255–261.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Brugada, J. Brugada, and R. Brugada The yet unresolved dilemma of syncope in Brugada syndrome Europace, January 1, 2001; 3(2): 157 - 158. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||